Antiangiogenic therapy in hematologic malignancies

Angiogenesis is defined as the formation of new capillaries from prexisting blood vessels and plays an important role in the progression of solid tumors an...

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Möhler, Thomas (VerfasserIn) , Hillengaß, Jens (VerfasserIn) , Goldschmidt, Hartmut (VerfasserIn) , Ho, Anthony Dick (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: [2004]
In: Current pharmaceutical design
Year: 2004, Jahrgang: 10, Heft: 11, Pages: 1221-1234
ISSN:1873-4286
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://www.eurekaselect.com/62218/article
Volltext
Verfasserangaben:T.M. Moehler, J. Hillengass, H. Goldschmidt, A.D. Ho

MARC

LEADER 00000caa a22000002c 4500
001 1780225210
003 DE-627
005 20230427104151.0
007 cr uuu---uuuuu
008 211203s2004 xx |||||o 00| ||eng c
035 |a (DE-627)1780225210 
035 |a (DE-599)KXP1780225210 
035 |a (OCoLC)1341430994 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Möhler, Thomas  |e VerfasserIn  |0 (DE-588)1014877261  |0 (DE-627)705298051  |0 (DE-576)34979572X  |4 aut 
245 1 0 |a Antiangiogenic therapy in hematologic malignancies  |c T.M. Moehler, J. Hillengass, H. Goldschmidt, A.D. Ho 
264 1 |c [2004] 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 03.12.2021 
520 |a Angiogenesis is defined as the formation of new capillaries from prexisting blood vessels and plays an important role in the progression of solid tumors an... 
700 1 |a Hillengaß, Jens  |d 1974-  |e VerfasserIn  |0 (DE-588)124918549  |0 (DE-627)368073823  |0 (DE-576)294568298  |4 aut 
700 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
700 1 |a Ho, Anthony Dick  |d 1948-  |e VerfasserIn  |0 (DE-588)108692477  |0 (DE-627)504904205  |0 (DE-576)19010466X  |4 aut 
773 0 8 |i Enthalten in  |t Current pharmaceutical design  |d Hilversum : Bentham Science Publ., 2000  |g 10(2004), 11, Seite 1221-1234  |h Online-Ressource  |w (DE-627)325051666  |w (DE-600)2034245-7  |w (DE-576)273880217  |x 1873-4286  |7 nnas  |a Antiangiogenic therapy in hematologic malignancies 
773 1 8 |g volume:10  |g year:2004  |g number:11  |g pages:1221-1234  |g extent:14  |a Antiangiogenic therapy in hematologic malignancies 
856 4 0 |u https://www.eurekaselect.com/62218/article  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20211203 
993 |a Article 
994 |a 2004 
998 |g 108692477  |a Ho, Anthony Dick  |m 108692477:Ho, Anthony Dick  |d 910000  |d 910100  |e 910000PH108692477  |e 910100PH108692477  |k 0/910000/  |k 1/910000/910100/  |p 4  |y j 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |d 50000  |e 910000PG102258023X  |e 910100PG102258023X  |e 50000PG102258023X  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 3 
998 |g 124918549  |a Hillengaß, Jens  |m 124918549:Hillengaß, Jens  |d 910000  |d 910100  |e 910000PH124918549  |e 910100PH124918549  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1014877261  |a Möhler, Thomas  |m 1014877261:Möhler, Thomas  |d 910000  |d 910100  |e 910000PM1014877261  |e 910100PM1014877261  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1780225210  |e 4013587475 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1780225210","origin":[{"dateIssuedKey":"2004","dateIssuedDisp":"[2004]"}],"physDesc":[{"extent":"14 S."}],"id":{"eki":["1780225210"]},"note":["Gesehen am 03.12.2021"],"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"325051666","origin":[{"publisherPlace":"Hilversum","dateIssuedDisp":"2000-","publisher":"Bentham Science Publ.","dateIssuedKey":"2000"}],"note":["Gesehen am 15.04.24"],"disp":"Antiangiogenic therapy in hematologic malignanciesCurrent pharmaceutical design","id":{"issn":["1873-4286"],"zdb":["2034245-7"],"eki":["325051666"]},"physDesc":[{"extent":"Online-Ressource"}],"part":{"text":"10(2004), 11, Seite 1221-1234","year":"2004","volume":"10","issue":"11","pages":"1221-1234","extent":"14"},"language":["eng"],"title":[{"subtitle":"dispatches from the front line of drug design","title":"Current pharmaceutical design","title_sort":"Current pharmaceutical design"}],"pubHistory":["Nachgewiesen 6.2000 -"]}],"name":{"displayForm":["T.M. Moehler, J. Hillengass, H. Goldschmidt, A.D. Ho"]},"person":[{"family":"Möhler","given":"Thomas","role":"aut","display":"Möhler, Thomas"},{"family":"Hillengaß","display":"Hillengaß, Jens","role":"aut","given":"Jens"},{"family":"Goldschmidt","role":"aut","given":"Hartmut","display":"Goldschmidt, Hartmut"},{"family":"Ho","display":"Ho, Anthony Dick","role":"aut","given":"Anthony Dick"}],"title":[{"title":"Antiangiogenic therapy in hematologic malignancies","title_sort":"Antiangiogenic therapy in hematologic malignancies"}],"language":["eng"]} 
SRT |a MOEHLERTHOANTIANGIOG2004